| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.00093 | 1 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.00075 | 1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00066 | 1 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.00047 | 1 |